Cosyntropin Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.25 mg/mL
Reference Brands: Cortrosyn (USA)
Category:
Critical Care
Cosyntropin is available in Injection
and strengths such as 0.25 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cosyntropin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cosyntropin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
osyntropin is a synthetically derived subunit of the endogenous pituitary hormone adrenocorticotropic hormone (ACTH), consisting of the first 24 amino acids from its amino-terminal region. Marketed under the brand name Cortrosyn, it is formulated for injection and is intended primarily for diagnostic use rather than therapeutic purposes.
Cosyntropin mimics the activity of natural ACTH by stimulating the adrenal cortex to secrete specific steroid hormones, which can then be measured in the plasma to assess adrenal function. It is widely used in the cosyntropin stimulation test (CST), a dynamic diagnostic procedure for evaluating the hypothalamic-pituitary-adrenal (HPA) axis in patients suspected of adrenal insufficiency (AI).
Adrenal insufficiency is a potentially life-threatening condition with diverse clinical presentations, requiring careful and timely diagnostic evaluation. Early detection and monitoring through cosyntropin testing are critical to prevent serious complications, including adrenal crisis and death.
Cosyntropin provides clinicians with a reliable and rapid method for assessing adrenal function, making it an essential tool in endocrinology and critical care settings. Its injectable formulation allows precise dosing and controlled assessment under medical supervision.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing